Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Global effort against rare and orphan diseases

Sergio Harari, Vincent Cottin, Marc Humbert
European Respiratory Review 2012 21: 171-172; DOI: 10.1183/09059180.00004112
Sergio Harari
*Unità Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria –Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare-Ospedale San Giuseppe MultiMedica, Milan, Italy. #Centre National de référence des maladies pulmonaires rares et Centre de compétences de l'hypertension artérielle pulmonaire, Hospices Civils de Lyon, Service de pneumologie, Hôpital Louis Pradel, Université de Lyon, Université Claude Bernard Lyon I, INRA, UMR754 IFR 128, Lyon, and ¶Centre National de Référence de l'Hypertension Pulmonaire Sévère, Hôpital Bicêtre, Hôpitaux Universitaires Paris-Sud, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sharari@hotmail.it
Vincent Cottin
*Unità Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria –Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare-Ospedale San Giuseppe MultiMedica, Milan, Italy. #Centre National de référence des maladies pulmonaires rares et Centre de compétences de l'hypertension artérielle pulmonaire, Hospices Civils de Lyon, Service de pneumologie, Hôpital Louis Pradel, Université de Lyon, Université Claude Bernard Lyon I, INRA, UMR754 IFR 128, Lyon, and ¶Centre National de Référence de l'Hypertension Pulmonaire Sévère, Hôpital Bicêtre, Hôpitaux Universitaires Paris-Sud, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Humbert
*Unità Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria –Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare-Ospedale San Giuseppe MultiMedica, Milan, Italy. #Centre National de référence des maladies pulmonaires rares et Centre de compétences de l'hypertension artérielle pulmonaire, Hospices Civils de Lyon, Service de pneumologie, Hôpital Louis Pradel, Université de Lyon, Université Claude Bernard Lyon I, INRA, UMR754 IFR 128, Lyon, and ¶Centre National de Référence de l'Hypertension Pulmonaire Sévère, Hôpital Bicêtre, Hôpitaux Universitaires Paris-Sud, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

The fifth International Congress on Rare Pulmonary Diseases and Orphan Drugs will take place in Milan, Italy, on February 8–9, 2013 (www.pulmonaryrarediseases.com). 10 yrs have passed since the first Congress was held. Since then, the Congress has taken place regularly every 2 yrs, with growing success and ever increasing numbers of participants and speakers from around the world. The International Congress on Rare Pulmonary Diseases and Orphan Drugs is the only European event dedicated to different types of rare pulmonary diseases affecting both parenchymal and vascular structures. Overall, more than 150 speakers and 650 participants have attended the past four Congresses, where scientific programmes are designed to build bridges between physicians specialised in the management of different lung disorders that have the common feature of being rare diseases, i.e. with prevalence lower than one per 2,000 persons according to the European definition.

Proceedings from the 2005 and 2009 Congresses have been published previously elsewhere [1, 2]. In the present issue of the European Respiratory Review (ERR), three selected articles focus on some of the most important and widely discussed topics from the fourth Congress held on February 25–26, 2011 [3–5]. These manuscripts summarise the two main scientific areas of discussion: 1) the basic science research, and 2) the prognostic evaluation …

View Full Text
PreviousNext
Back to top
View this article with LENS
Vol 21 Issue 125 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Global effort against rare and orphan diseases
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Global effort against rare and orphan diseases
Sergio Harari, Vincent Cottin, Marc Humbert
European Respiratory Review Sep 2012, 21 (125) 171-172; DOI: 10.1183/09059180.00004112

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Global effort against rare and orphan diseases
Sergio Harari, Vincent Cottin, Marc Humbert
European Respiratory Review Sep 2012, 21 (125) 171-172; DOI: 10.1183/09059180.00004112
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Clinical and prognostic value of ventilatory efficiency in cardiorespiratory disorders
  • Guidance production before evidence generation for critical issues: COVID-19
  • Modulator treatment for people with cystic fibrosis
Show more Editorial

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2022 by the European Respiratory Society